The Gross Margin of Ocumension Therapeutics (1477.HK) is 44.87%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 44.87% |
| 2024-12-31 | 53.93% |
| 2023-12-31 | 58.60% |
| 2022-12-31 | 64.74% |
| 2021-12-31 | 65.78% |
| 2020-12-31 | 86.84% |
| 2019-12-31 | 94.74% |
| 2018-12-31 | 94.74% |